Publication Cover
Journal of Dual Diagnosis
research and practice in substance abuse comorbidity
Volume 14, 2018 - Issue 3
522
Views
5
CrossRef citations to date
0
Altmetric
Articles

Comorbid Cannabis and Tobacco Use Disorders in Hospitalized Patients with Psychotic-Spectrum Disorders

, PhD ORCID Icon, , PhD, , PhD, , BS, , BS, , BA, , PhD & , MD show all
Pages 171-180 | Received 09 Nov 2017, Accepted 13 Apr 2018, Published online: 28 Sep 2018

References

  • Addington, J., & Addington, D. (2007). Patterns, predictors and impact of substance use in early psychosis: A longitudinal study. Acta Psychiatrica Scandinavica, 115, 304–309. doi:10.1111/j.1600-0447.2006.00900.x
  • Agosti, V., Nunes, E., & Levin, F. (2002). Rates of psychiatric comorbidity among U.S. residents with lifetime cannabis dependence. The American Journal of Drug and Alcohol Abuse, 28, 643–652. doi:10.1081/ADA-120015873
  • Aguilar, M. C., Gurpegui, M., Diaz, F. J., & De Leon, J. (2005). Nicotine dependence and symptoms in schizophrenia: Naturalistic study of complex interactions. The British Journal of Psychiatry, 186, 215–221. doi:10.1192/bjp.186.3.215
  • Arrazola, R. A., Singh, T., Corey, C. G., Husten, C. G., Neff, L. J., Apelberg, B. J., … Caraballo, R. S. (2015). Tobacco use among middle and high school students – United States, 2011–2014. Morbidity and Mortality Weekly Report, 64, 381–385. doi:10.15585/mmwr.mm6514a1
  • Auther, A., McLaughlin, D., Carrión, R., Nagachandran, P., Correll, C., Cornblatt, B. (2012). Prospective study of cannabis use in adolescents at clinical high risk for psychosis: Impact on conversion to psychosis and functional outcome. Psychological Medicine, 42, 2485–2497. doi:10.1017/S0033291712000803
  • Baker, A., Bucci, S., Lewin, T. J., Kay-Lambkin, F., Constable, P. M., & Carr, V. J. (2006). Cognitive-behavioural therapy for substance use disorders in people with psychotic disorders: Randomised controlled trial. British Journal of Psychiatry, 188, 439–448. doi:10.1192/bjp.188.5.439
  • Baker, A., Lewin, T., Reichler, H., Clancy, R., Carr, V., Garrett, R., …Terry, M. (2002). Evaluation of a motivational interview for substance use within psychiatric in-patient services. Addiction, 97, 1329–1337. doi:10.1046/j.1360-0443.2002.00178.x
  • Baker, A., Richmond, R., Haile, M., Lewin, T. J., Carr, V. J., Taylor, R. L., … Wilhelm, K. (2006). A randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder. American Journal of Psychiatry, 163, 1934–1942. doi:10.1176/ajp.2006.163.11.1934
  • Ballon, J., & Stroup, T. (2013). Polypharmacy for schizophrenia. Current Opinion in Psychology, 26, 208–213. doi:10.1097/YCO.0b013e32835d9efb
  • Barrowclough, C., Haddock, G., Wykes, T., Beardmore, R., Conrod, P., Craig, T., … Tarrier, N. (2010). Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: Randomised controlled trial. British Medical Journal, 341, c6325. doi:10.1136/bmj.c6325
  • Bersani, G., Orlandi, V., Kotzalidis, G. D., & Pancheri, P. (2002). Cannabis and schizophrenia: Impact on onset, course, psychopathology and outcomes. European Archives of Psychiatry and Clinical Neuroscience, 252, 86–92. doi:10.1007/s00406-002-0366-5
  • Blanco, C., Hasin, D. S., Wall, M. M., Flórez-Salamanca, L., Hoertel, N., Wang, S., … Olfson, M. (2016). Cannabis use and risk of psychiatric disorders: Prospective evidence from a US national longitudinal study. JAMA Psychiatry, 73, 388–395. doi:10.1001/jamapsychiatry.2015.3229
  • Breslau, N., & Johnson, E. O. (2000). Predicting smoking cessation and major depression in nicotine-dependent smokers. American Journal of Public Health, 90, 1122–1127. doi:10.2105/AJPH.90.7.1122
  • Breslau, N., Kilbey, M. M., & Andreski, P. (1991). Nicotine dependence, major depression, and anxiety in young adults. Archives of General Psychiatry, 48, 1069–1074. doi:10.1001/archpsyc.1991.01810360033005
  • Carr, J. A., Norman, R. M., & Manchanda, R. (2009). Substance misuse over the first 18 months of specialized intervention for first episode psychosis. Early Intervention in Psychiatry, 3, 221–225. doi:10.1111/j.1751-7893.2009.00136.x
  • Centers for Disease Control (CDC). (2008). Smoking-attributable mortality, years of potential life lost, and productivity losses – Years of potential life – United States, 2000–2004. Morbidity and Mortality Weekly Report, 57, 1226–1228.
  • Compton, M. T., Broussard, B., Ramsay, C. E., & Stewart, T. (2011). Pre-illness cannabis use and the early course of nonaffective psychotic disorders: Associations with premorbid functioning, the prodrome, and mode of onset of psychosis. Schizophrenia Research, 126(1–3), 71–76. doi:10.1016/j.schres.2010.10.005
  • Compton, M. T., Kelley, M. E., Ramsay, C. E., Pringle, M., Goulding, S. M., Esterberg, M. L., … Walker, E. F. (2009). Association of pre-onset cannabis, alcohol, and tobacco use with age at onset of prodrome and age at onset of psychosis in first-episode patients. The American Journal of Psychiatry, 166, 1251–1257. doi:10.1176/appi.ajp.2009.09030311
  • Conway, K. P., Compton, W., Stinson, F. S., & Grant, B. F. (2006). Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. The Journal of Clinical Psychiatry, 67(2), 247–257. doi:10.4088/JCP.v67n0211
  • De Leon, J., & Diaz, F. J. (2005). A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophrenia Research, 76(2–3), 135–157. doi:10.1016/j.schres.2005.02.010
  • Degenhardt, L., Hall, W., & Lynskey, M. (2001). Alcohol, cannabis and tobacco use among Australians: A comparison of their associations with other drug use and use disorders, affective and anxiety disorders, and psychosis. Addiction, 96, 1603–1614. doi:10.1046/j.1360-0443.2001.961116037.x
  • Dixon, L., Medoff, D. R., Wohlheiter, K., DiClemente, C., Goldberg, R., Kreyenbuhl, J., … Davin, C. (2007). Correlates of severity of smoking among persons with severe mental illness. American Journal on Addictions, 16, 101–110. doi:10.1080/10550490601184415
  • Falk, D., Yi, H. Y., & Hiller-Sturmhöfel, S. (2008). An epidemiologic analysis of co-occurring alcohol and drug use and disorders. Alcohol Research and Health, 31, 100–110.
  • Gaudiano, B. A., Weinstock, L. M., Epstein-Lubow, G., Uebelacker, L. A., & Miller, I. W. (2016). Clinical characteristics and medication use patterns among hospitalized patients admitted with psychotic vs nonpsychotic major depressive disorder. Annals of Clinical Psychiatry: Official Journal of the American Academy of Clinical Psychiatrists, 28, 56–63.
  • Goff, D. C., Henderson, D. C., & Amico, B. S. (1992). Cigarette smoking in schizophrenia: Relationship to psychopathology and medication side effects. American Journal of Psychiatry, 149, 1189–1194. doi:10.1176/ajp.149.9.1189
  • González-Blanch, C., Gleeson, J. F., Koval, P., Cotton, S. M., McGorry, P. D., & Alvarez-Jimenez, M. (2015). Social functioning trajectories of young first-episode psychosis patients with and without cannabis misuse: A 30-month follow-up study. PloS One, 10, 1–14. doi:10.1371/journal.pone.0122404
  • Hahn, L., Rigby, A., & Galletly, C. (2014). Determinants of high rates of smoking among people with psychosis living in a socially disadvantaged region in South Australia. Australian and New Zealand Journal of Psychiatry, 48, 70–79. doi:10.1177/0004867413491158
  • Hasin, D. S., Kerridge, B. T., Saha, T. D., Huang, B., Pickering, R., Smith, S. M., … Grant, B. F. (2016). Prevalence and correlates of DSM-5 cannabis use disorder, 2012–2013: Findings from the national epidemiologic survey on alcohol and related conditions-III. American Journal of Psychiatry, 173, 588–599. doi:10.1176/appi.ajp.2015.15070907
  • Hasin, D. S., Saha, T. D., Kerridge, B. T., Goldstein, R. B., Chou, S. P., Zhang, H., … Grant, B. F. (2015). Prevalence of marijuana use disorders in the United States between 2001–2002 and 2012–2013. JAMA Psychiatry, 72, 1235–1242. doi:10.1001/jamapsychiatry.2015.1858
  • Hulse, G. K., & Tait, R. J. (2003). Five-year outcomes of a brief alcohol intervention for adult in-patients with psychiatric disorders. Addiction, 98, 1061–1068. doi:10.1046/j.1360-0443.2003.00404.x
  • Johnston, L. D., O’Malley, P. M., Bachman, J. G., Schulenberg, J. E., & Miech, R. A. (2015). Monitoring the future national survey results on drug use, 1975–2014: Volume 2, college students and adults ages 19–55. Ann Arbor: Institute for Social Research, The University of Michigan.
  • Kalman, D., Morissette, S. B., & George, T. P. (2005). Co-morbidity of smoking in patients with psychiatric and substance use disorders. The American Journal on Addictions, 14, 106–123. doi:10.1080/10550490590924728
  • Karam, E. G., Yabroudi, P. F., & Melhem, N. M. (2002). Comorbidity of substance abuse and other psychiatric disorders in acute general psychiatric admissions: A study from Lebanon. Comprehensive Psychiatry, 43, 463–468. doi:10.1053/comp.2002.35910
  • Kavanagh, D. J., Waghorn, G., Jenner, L., Chant, D. C., Carr, V., Evans, M., … McGrath, J. J. (2004). Demographic and clinical correlates of comorbid substance use disorders in psychosis: Multivariate analyses from an epidemiological sample. Schizophrenia Research, 66(2–3), 115–124. doi:10.1016/S0920-9964(03)00130-0
  • Kavanagh, D. J., Young, R., White, A., Saunders, J. B., Wallis, J., Shockley, N., … Clair, A. (2004). A brief motivational intervention for substance misuse in recent-onset psychosis. Drug and Alcohol Review, 32, 151–155
  • Kelly, C., & McCreadie, R. (2000). Cigarette smoking and schizophrenia. Advances in Psychiatric Treatment, 6, 327–331. doi:10.1192/apt.6.5.327
  • Koskinen, J., Löhönen, J., Koponen, H., Isohanni, M., & Miettunen, J. (2010). Rate of cannabis use disorders in clinical samples of patients with schizophrenia: A meta-analysis. Schizophrenia Bulletin, 36, 1115–1130. doi:10.1093/schbul/sbp031
  • Kristensen, K., & Cadenhead, K. S. (2007). Cannabis abuse and risk for psychosis in a prodromal sample. Psychiatry Research, 151(1–2), 151–154. doi:10.1016/j.psychres.2006.10.001
  • Lasser, K., Boyd, J. W., Woolhandler, S., Himmelstein, D. U., McCormick, D., & Bor, D. H. (2000). Smoking and mental illness. The Journal of the American Medical Association, 284, 2606. doi:10.1001/jama.284.20.2606
  • Leeson, V. C., Harrison, I., Ron, M. A., Barnes, T. R. E., & Joyce, E. M. (2012). The effect of cannabis use and cognitive reserve on age at onset and psychosis outcomes in first-episode schizophrenia. Schizophrenia Bulletin, 38, 873–880. doi:10.1093/schbul/sbq153
  • Long, J., & Freese, J. (2006). Regression Models for Categorical and Limited Dependent Variables Using Stata (Second Edition). College Station, TX: Stata Press.
  • Meier, M. H., Caspi, A., Ambler, A., Harrington, H., Houts, R., Keefe, R. S. E., … Moffitt, T. E. (2012). Persistent cannabis users show neuropsychological decline from childhood to midlife. Proceedings of the National Academy of Sciences, 109, E2657–E2664. doi:10.1073/pnas.1206820109
  • Meier, M. H., Caspi, A., Cerdá, M., Hancox, R. J., Harrington, H., Houts, R., … Moffitt, T. E. (2016). Associations between cannabis use and physical health problems in early midlife: A longitudinal comparison of persistent cannabis vs tobacco users. JAMA Psychiatry, 73(7), 731–740. doi:10.1001/jamapsychiatry.2016.0637
  • Pacek, L. R., Mauro, P. M., & Martins, S. S. (2015). Perceived risk of regular cannabis use in the United States from 2002 to 2012: Differences by sex, age, and race/ethnicity. Drug and Alcohol Dependence, 149, 232–244. doi:10.1016/j.drugalcdep.2015.02.009
  • Peters, B. D., de Koning, P., Dingemans, P. M., Becker, H., Linszen, D. H., & de Haan, L. (2009). Subjective effects of cannabis before the first psychotic episode. The Australian and New Zealand Journal of Psychiatry, 43, 1155–1162. doi:10.3109/00048670903179095
  • Peters, E. N., Schwartz, R. P., Wang, S., O’Grady, K. E., & Blanco, C. (2014). Psychiatric, psychosocial, and physical health correlates of co-occurring cannabis use disorders and nicotine dependence. Drug and Alcohol Dependence, 134, 228–234. doi:10.1016/j.drugalcdep.2013.10.003
  • Prochaska, J. J., Hall, S. E., Delucchi, K., & Hall, S. M. (2014). Efficacy of initiating tobacco dependence treatment in inpatient psychiatry: A randomized controlled trial. American Journal of Public Health, 104, 1557–1565. doi:10.2105/AJPH.2013.301403
  • Salyers, M. P., & Mueser, K. T. (2001). Social functioning, psychopathology, and medication side effects in relation to substance use and abuse in schizophrenia. Schizophrenia Research, 48, 109–123. doi:10.1016/S0920-9964(00)00063-3
  • Schoeler, T., Monk, A., Sami, M. B., Klamerus, E., Foglia, E., Brown, R., … Bhattacharyya, S. (2016). Continued versus discontinued cannabis use in patients with psychosis: A systematic review and meta-analysis. The Lancet Psychiatry, 3, 215–225. doi:10.1016/S2215-0366(15)00363-6
  • Spencer, C., Castle, D., & Michie, P. T. (2002). Motivations that maintain substance use among individuals with psychotic disorders. Schizophrenia Bulletin, 28, 233–247. doi:10.1093/oxfordjournals.schbul.a006934
  • Stinson, F. S., Grant, B. F., Dawson, D. A., Ruan, W. J., Huang, B., & Saha, T. (2005). Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug & Alcohol Dependence, 80, 105–116. doi:10.1016/j.drugalcdep.2005.03.009
  • Stinson, F. S., Ruan, W. J., Pickering, R., & Grant, B. F. (2006). Cannabis use disorders in the USA: Prevalence, correlates and co-morbidity. Psychological Medicine, 36, 1447–1460. doi:10.1017/S0033291706008361
  • Subbaraman, M. S., Metrik, J., Patterson, D., & Swift, R. (2017). Cannabis use during treatment for alcohol use disorders predicts alcohol treatment outcomes. Addiction, 112, 685–694. doi:10.1111/add.13693
  • Thornton, L. K., Baker, A. L., Johnson, M. P., Kay-Lambkin, F., & Lewin, T. J. (2012). Reasons for substance use among people with psychotic disorders: Method triangulation approach. Psychology of Addictive Behaviors, 26, 279–288. doi:10.1037/a0026469
  • Van Dam, N. T., Earleywine, M., & DiGiacomo, G. (2008). Polydrug use, cannabis, and psychosis-like symptoms. Human Psychopharmacology Clinical and Experimental, 23, 475–485. doi:10.1002/hup.950
  • van Gastel, W. A., MacCabe, J. H., Schubart, C. D., Vreeker, A., Tempelaar, W., Kahn, R. S., … Boks, M. P. M. (2013). Cigarette smoking and cannabis use are equally strongly associated with psychotic-like experiences: A cross-sectional study in 1929 young adults. Psychological Medicine, 43, 2393–2401. doi:10.1017/S0033291713000202
  • Volkow, N. D., Baler, R. D., Compton, W. M., & Weiss, S. R. B. (2014). Adverse health effects of marijuana use. The New England Journal of Medicine, 370, 2219–2227. doi:10.1056/NEJMra1402309
  • Winterer, G. (2010). Why do patients with schizophrenia smoke? Current Opinion in Psychiatry, 23, 112–119. doi:10.1097/YCO.0b013e3283366643
  • Ziedonis, D., Hitsman, B., Beckham, J. C., Zvolensky, M., Adler, L. E., Audrain-McGovern, J., … Riley, W. T. (2008). Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine & Tobacco Research, 10, 1691–1715. doi:10.1080/14622200802443569

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.